Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Formato: Artigo
Idioma:Inglês
Publicado: BMC 2020-11-01
Series:Cell & Bioscience
Assuntos:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
Acceso en liña:http://link.springer.com/article/10.1186/s13578-020-00492-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares